CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world. CryoHoldco is now seven times larger than any other stem cell bank in Latin America and has over 275,000 stem cell units in storage.
Cryoholdco was created in 2015 with the purpose of forming the premier stem cell banking company in Latin America. The first asset it acquired was Cryo-Cell Mexico, which coincidentally, was first stem cell bank formed in Latin America. Since investing in Cryo-Cell Mexico in mid 2015, CryoHoldco has been aggressively consolidating the Latin American market.
Next, CryoHoldco acquired a controlling interest in a regional stem cell bank in Mexico in Q4 of 2015. In early 2016, it then acquired Stem Medicina Regenerativa, the largest stem cell bank in Colombia.
Today, Cryoholdco controls the following cord blood banking assets:
- Cryo-Cell Mexico
- DentCell (Dental stem cell storage company)
- Two assets in Columbia
- It recently acquired two assets in Brazil
As a result of this expansion, CryoHoldco represents the largest stem cell banking operation in Latin America. The company features two state-of-the art lab and storage facilities in Mexico and Colombia, as well as a growing network of 10,000+ affiliated doctors and 100+ sales offices. CryoHoldco’s state-of–the-art storage facility in Guadalajara, Mexico, has the capacity to store 300,000 samples.
Its companies are the market leaders within their country and offer services nationwide.
According to Cryoholdco leadership, the market must be consolidated so the larger companies can “increase their investment in technology, state –of- the-art storage facilities, participate in clinical trials, improve operating performance, and invest in educational programs with doctors and clients to convey the benefits of storing cord blood and tissue.”
For additional details on Cryoholdco, read our interview with its CFO, James Alexis Mendez.